[182]
Moreover, it notes that the '840 patent had already disclosed that its compounds achieved "more excellent antibacterial activity" and "low toxicity". In addition, the '840 patent compounds of its invention have a high degree of water solubility as it states that these compounds could be administered by injection. ('840 patent, p. 3, l. 5-8, p. 27, l. 2-3, Apotex Doc. 75, AR, v. 39, Tab 59(75), p. 12398, l. 5-8, p. 12422, l. 2-3; Kellogg Affidavit at para. 106, AR, v. 47, Tab 69, pp. 15153-15154.)